Synapse - Mark Kris

Results (168)

EGFR and KRAS mutations are molecular predictors of survival in resected lung adenocarcinoma

Meeting Abstract

Marks, J. L.; Broderick, S.; Seshan, V. E.; Zakowski, M. F.; Li, A.; Wilson, R.; Kris, M. G.; Ladanyi, M.; Rusch, V. W.; Pao, W.
Journal of Thoracic Oncology (2007)

Fulltext@MSK | Save

Prospective trial of preoperative gefitinib to correlate response with EGFR exon 19 and 21 mutations and to select patients for adjuvant gefitinib

Meeting Abstract

Kris, M. G.; Pao, W.; Zakowski, Maureen F; Ladanyi, M.; Heelan, R. T.; Schwartz, L.; Zhao, B.; Venkatraman, E.; Rusch, V.; Rizvi, N. A.
Journal of Thoracic Oncology (2007)

Fulltext@MSK | Save

Interim results of two prospective trials measuring plasma total DNA and methylated genes before and after surgery or chemotherapy in patients with non-small cell lung cancer (NSCLC)

Meeting Abstract

Azzoli, C. G.; Kobayashi, H.; Park, S.; Ginex, P.; Vincent, A.; Jones, J.; Venkatraman, E.; Danenberg, K.; Danenberg, P.; Rusch, V. R.; more...
International Journal of Biological Markers (2007)

Fulltext@MSK | Save

Phase II trial of pralatrexate (10-propargyl-10-deazaaminopterin, PDX) in patients with unresectable malignant pleural mesothelioma

Journal Article

Krug, L. M.; Heelan, R. T.; Kris, M. G.; Venkatraman, E.; Sirotnak, F. M.
Journal of Thoracic Oncology (2007)

Fulltext@MSK | Save

Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy

Journal Article

Basch, E.; Iasonos, A.; Barz, A.; Culkin, A.; Kris, M. G.; Artz, D.; Fearn, P.; Speakman, J.; Farquhar, R.; Scher, H. I.; more...
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

A phase II tolerability study of cisplatin plus docetaxel as adjuvant chemotherapy for resected non-small cell lung cancer

Journal Article

Azzoli, C. G.; Krug, L. M.; Miller, V. A.; Rizvi, N. A.; Kris, M. G.; Dunne, M.; Farmer, A.; Pizzo, B.; Tyson, L.; Seeger, T.; more...
Journal of Thoracic Oncology (2007)

Fulltext@MSK | Save

A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors

Journal Article

Azzoli, C. G.; Krug, L. M.; Gomez, J.; Miller, V. A.; Kris, M. G.; Ginsberg, M. S.; Henry, R.; Jones, J.; Tyson, L.; Dunne, M.; more...
Clinical Cancer Research (2007)

Fulltext@MSK | Save

Prospective trial with preoperative gefitinib to correlate lung cancer response with EGFR exon 19 and 21 mutations and to select patients for adjuvant therapy

Meeting Abstract

Kris, M. G.; Pao, W.; Zakowski, M. F.; Ladanyi, M.; Heelan, R. T.; Schwartz, L.; Zhao, B.; Venkatraman, E.; Rusch, V.; Rizvi, N. A.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events

Meeting Abstract

Basch, E. M.; McDonough, T.; Iasonos, A.; Siegel, E.; Culkin, A.; Kris, M.; Scher, H. I.; Schrag, D.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Interim results of two prospective trials measuring plasma total DNA and methylated genes before and after surgery, or chemotherapy, in patients with non-small cell lung cancer (NSCLC)

Meeting Abstract

Azzoli, C. G.; Park, S.; Ginex, P.; Vincent, A.; Jones, J.; Venkatraman, E.; Danenberg, K.; Danenberg, P.; Rusch, V. R.; Kris, M. G.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save